Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- Funder
- National Institutes of Health
- Award amount
- Not specified
- Deadline
- December 3, 2026
- Eligible countries
- United States
Summary
This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.
Summary as listed on Grants.gov (opportunity 356724). Always read the full announcement for eligibility, limits and how to apply.
Read the full announcement on Grants.gov →What National Institutes of Health reviewers look for
- Importance of the research (significance and innovation), scored 1–9.
- Rigor and feasibility of the approach, scored 1–9. Preliminary data and alternative strategies carry much of this.
- Expertise and resources, rated sufficient or not, without a score.
- Overall impact: the likelihood the project will have a sustained, powerful influence on its field.
Read our guide: what funded applications do →
See how this call matches your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free